ArticleBMJ public health2026
Health worker practices and challenges surrounding routine immunisation service delivery of measles-containing vaccine: a cross-sectional assessment of health facilities in Oromia region, Ethiopia - 2021.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ethiopia's routine immunisation schedule has included the first dose of measles-containing vaccine (MCV1) since 1980, and MCV2 was introduced in 2019. However, challenges with MCV service delivery and frontline health worker (HW) practices persist. Methods: A cross-sectional assessment was conducted between February and March 2021 among HWs (n=72) and Expanded Program on Immunization (EPI) focal persons (n=29) from 18 randomly selected districts and 36 health facilities that provide vaccination in Oromia, Ethiopia. Participants were interviewed about their practices during vaccination sessions, the availability of updated reporting tools for MCV2, the cold-chain system, immunisation programme operations and vaccine supply monitoring. Data management and descriptive analyses were carried out using R. Results: Among HWs, 76% and 40% reported offering MCV at every static and outreach vaccination session, respectively, 72% needed at least five children to open a 10-dose MCV vial, 13% reported recent (past 12 months) cancellation of MCV sessions due to vaccine stock-outs and 29% regularly discussed with the performance monitoring team. The availability of updated reporting tools varied; 36% had updated immunisation registers, 40% had updated tally sheets, 63% had updated vaccination cards and 76% had updated monthly reporting forms. District EPI focal persons reported inconsistent power supply (68%) and at least one recent vaccine stock-out (17%). Conclusions: Inconsistent delivery of MCV at all vaccination sessions and the reluctance of HWs to open the measles vaccine vial could lead to missed opportunities for measles vaccination. MCV coverage could be improved by switching to a five-dose MCV vial, re-enforcing HW training in open vial policies and session management, ensuring availability of updated monitoring tools and monitoring vaccine stock.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.